{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:59:55Z","timestamp":1781715595917,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22615-5","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T06:52:22Z","timestamp":1744699942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surveillance of psychogenic adverse events following immunization in Zhejiang, China, 2020\u20132023"],"prefix":"10.1186","volume":"25","author":[{"given":"Xuejiao","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"2","key":"22615_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ejhf.2716","volume":"25","author":"A Peikert","year":"2023","unstructured":"Peikert A, Claggett BL, Kim K, Udell JA, Joseph J, Desai AS, Farkouh ME, Hegde SM, Hernandez AF, Bhatt DL, et al. Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial. Eur J Heart Fail. 2023;25(2):299\u2013310.","journal-title":"Eur J Heart Fail"},{"key":"22615_CR2","unstructured":"World Health Organization. Causality assessment of an adverse event following immunization (AEFI). 2nd ed. World Health Organization; 2019."},{"key":"22615_CR3","unstructured":"World Health Organization. COVID-19 vaccines: safety surveillance manual. World Health Organization; 2021."},{"key":"22615_CR4","unstructured":"VAERS. Vaccine Adverse Event Reporting System. Available online: https:\/\/vaers.hhs.gov\/about.html (accessed on 15 September 2024)."},{"issue":"5","key":"22615_CR5","doi-asserted-by":"publisher","first-page":"e12565","DOI":"10.1002\/emp2.12565","volume":"2","author":"T Kewan","year":"2021","unstructured":"Kewan T, Flores M, Mushtaq K, Alwakeel M, Burton R, Campbell J, Perry H, Al-Jaghbeer M, Abi Fadel F. Characteristics and outcomes of adverse events after COVID-19 vaccination. J Am Coll Emerg Physicians Open. 2021;2(5):e12565.","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"22615_CR6","unstructured":"World Health Organization. Global Manual on Surveillance of Adverse Events Following Immunization[S]. 2012-03."},{"key":"22615_CR7","unstructured":"WHO. (2018). Causality assessment of an adverse event following immunizagion (AEFI): User manual for the revised WHO classification (2nd ed.)."},{"issue":"2","key":"22615_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.vaccine.2017.11.017","volume":"36","author":"A Loharikar","year":"2018","unstructured":"Loharikar A, Suragh TA, MacDonald NE, Balakrishnan MR, Benes O, Lamprianou S, Hyde TB, McNeil MM. Anxiety-related adverse events following immunization (AEFI): A systematic review of published clusters of illness. Vaccine. 2018;36(2):299\u2013305.","journal-title":"Vaccine"},{"issue":"3","key":"22615_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/10253890.2015.1067678","volume":"18","author":"X Belda","year":"2015","unstructured":"Belda X, Fuentes S, Daviu N, Nadal R, Armario A. Stress-induced sensitization: the hypothalamic-pituitary-adrenal axis and beyond. Stress. 2015;18(3):269\u201379.","journal-title":"Stress"},{"issue":"34","key":"22615_CR10","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","volume":"33","author":"NE MacDonald","year":"2015","unstructured":"MacDonald NE, Hesitancy SWGV. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161\u20134.","journal-title":"Vaccine"},{"key":"22615_CR11","doi-asserted-by":"crossref","unstructured":"Rodrigues F, Block S, Sood S. What determines vaccine hesitancy: recommendations from childhood vaccine hesitancy to address COVID-19 vaccine hesitancy. Vaccines (Basel) 2022, 10(1).","DOI":"10.3390\/vaccines10010080"},{"key":"22615_CR12","unstructured":"World Health Organization. Top Ten Threats to Global Health in 2019. Available online: https:\/\/www.who.int\/newsroom\/feature-stories\/ten-threats-to-global-health-in-2019. (accessed on 10 September2024)."},{"issue":"1 Suppl 1","key":"22615_CR13","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.amepre.2020.09.003","volume":"60","author":"AL Wagner","year":"2021","unstructured":"Wagner AL, Huang Z, Ren J, Laffoon M, Ji M, Pinckney LC, Sun X, Prosser LA, Boulton ML, Zikmund-Fisher BJ. Vaccine hesitancy and concerns about vaccine safety and effectiveness in Shanghai, China. Am J Prev Med. 2021;60(1 Suppl 1):S77\u201386.","journal-title":"Am J Prev Med"},{"issue":"38","key":"22615_CR14","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.1016\/j.vaccine.2023.07.043","volume":"41","author":"L Moscara","year":"2023","unstructured":"Moscara L, Venerito V, Martinelli A, Di Lorenzo A, Toro F, Violante F, Tafuri S, Stefanizzi P. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study. Vaccine. 2023;41(38):5655\u201361.","journal-title":"Vaccine"},{"issue":"1","key":"22615_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2021.2011652","volume":"18","author":"P Stefanizzi","year":"2022","unstructured":"Stefanizzi P, Bianchi FP, Spinelli G, Amoruso F, Ancona D, Stella P, Tafuri S. Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia region, 2014-19. Hum Vaccin Immunother. 2022;18(1):1\u20136.","journal-title":"Hum Vaccin Immunother"},{"key":"22615_CR16","doi-asserted-by":"crossref","unstructured":"Al-Worafi YM. Pharmacovigilance. Drug safety in developing countries. Academic; 2020. pp. 29\u201338.","DOI":"10.1016\/B978-0-12-819837-7.00004-2"},{"issue":"11","key":"22615_CR17","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1080\/21645515.2021.1965424","volume":"17","author":"F Aguirre-Boza","year":"2021","unstructured":"Aguirre-Boza F, San Martin PP, Valenzuela BM. How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile? Hum Vaccin Immunother. 2021;17(11):4225\u201334.","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"22615_CR18","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.jaip.2022.07.027","volume":"10","author":"K Imai","year":"2022","unstructured":"Imai K, Tanaka F, Kawano S, Esaki K, Arakawa J, Nishiyama T, Seno S, Hatanaka K, Sugiura T, Kodama Y, et al. Incidence and risk factors of immediate hypersensitivity reactions and immunization Stress-Related responses with COVID-19 mRNA vaccine. J Allergy Clin Immunol Pract. 2022;10(10):2667\u201376. e2610.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"22615_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1186\/s12879-024-09903-y","volume":"24","author":"L Zhang","year":"2024","unstructured":"Zhang L, Fu Y, Wang W, Liu Y, Hu R, Wang Z, Sun X. Surveillance of adverse events following varicella vaccine immunization in Jiangsu Province, China from 2017 to 2023. BMC Infect Dis. 2024;24(1):983.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"22615_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.vaccine.2021.01.048","volume":"39","author":"J Gao","year":"2021","unstructured":"Gao J, Tang F, Wang Z, Yu J, Hu R, Liu L, Kang G. Post-marketing safety surveillance for inactivated enterovirus 71 vaccines in Jiangsu, China from 2017 to 2019. Vaccine. 2021;39(9):1415\u20139.","journal-title":"Vaccine"},{"key":"22615_CR21","unstructured":"General Office of the National Health Commission. General Department of the State Food and Drug Administration. National surveillance plan for suspected abnormal vaccination reactions[S]. 2022-06-10."},{"key":"22615_CR22","doi-asserted-by":"crossref","unstructured":"Liang H, Qi X, Chen Y, Pan X. Surveillance of adverse events following varicella vaccine immunization in Zhejiang Province, China, from 2020 to 2022. Vaccines (Basel) 2025, 13(1).","DOI":"10.3390\/vaccines13010057"},{"issue":"02","key":"22615_CR23","first-page":"208","volume":"28","author":"KL Lina Zhang","year":"2022","unstructured":"Lina Zhang KL, Li Y, et al. Surveillance of suspected abnormal vaccination reactions in China in 2020. Chin Vaccines Immun. 2022;28(02):208\u201318.","journal-title":"Chin Vaccines Immun"},{"issue":"18","key":"22615_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.15585\/mmwr.mm7018e3","volume":"70","author":"AM Hause","year":"2021","unstructured":"Hause AM, Gee J, Johnson T, Jazwa A, Marquez P, Miller E, Su J, Shimabukuro TT, Shay DK. Anxiety-Related adverse event clusters after Janssen COVID-19 vaccination - Five U.S. Mass vaccination sites, April 2021. MMWR Morb Mortal Wkly Rep. 2021;70(18):685\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"22615_CR25","unstructured":"Wang G, Yao Y, Wang Y, Gong J, Meng Q, Wang H, Wang W, Chen X, Zhao Y. COVID-19 non-vaccination among older adults in China: a nationwide survey based on the China Health and Retirement Longitudinal Study (CHARLS). Res Sq 2022."},{"issue":"10","key":"22615_CR26","doi-asserted-by":"publisher","first-page":"e30765","DOI":"10.2196\/30765","volume":"23","author":"M Monselise","year":"2021","unstructured":"Monselise M, Chang CH, Ferreira G, Yang R, Yang CC. Topics and sentiments of public concerns regarding COVID-19 vaccines: social media trend analysis. J Med Internet Res. 2021;23(10):e30765.","journal-title":"J Med Internet Res"},{"key":"22615_CR27","doi-asserted-by":"crossref","unstructured":"Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines (Basel) 2020, 8(3).","DOI":"10.3390\/vaccines8030482"},{"key":"22615_CR28","doi-asserted-by":"crossref","unstructured":"Kong G, Lim NA, Chin YH, Ng YPM, Amin Z. Effect of COVID-19 pandemic on influenza vaccination intention: A Meta-Analysis and systematic review. Vaccines (Basel) 2022, 10(4).","DOI":"10.3390\/vaccines10040606"},{"key":"22615_CR29","doi-asserted-by":"publisher","first-page":"126265","DOI":"10.1016\/j.jclepro.2021.126265","volume":"295","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhang F. What does the China\u2019s economic recovery after COVID-19 pandemic mean for the economic growth and energy consumption of other countries? J Clean Prod. 2021;295:126265.","journal-title":"J Clean Prod"},{"key":"22615_CR30","unstructured":"Zhejiang Provincial Department of Health, Zhejiang Provincial Department of Education. Notice on issuing the implementation plan for the enhanced immunization of leprosy vaccine for junior high school students in Zhejiang Province.2011-09-30. Accessed on 10 September 2024."},{"issue":"19","key":"22615_CR31","doi-asserted-by":"publisher","first-page":"1800380","DOI":"10.2807\/1560-7917.ES.2019.24.19.1800380","volume":"24","author":"D Ward","year":"2019","unstructured":"Ward D, Thorsen NM, Frisch M, Valentiner-Branth P. K\u00e5re M\u00f8lbak, and Anders hviid.: A cluster analysis of serious adverse event reports after human papillomavirus (HPV) vaccination in Danish girls and young women, September 2009 to August 2017. Eurosurveillance. 2019;24(19):1800380.","journal-title":"Eurosurveillance"},{"key":"22615_CR32","first-page":"1","volume-title":"Manual on surveillance of adverse events following immunization[M]","author":"WHO.Global","year":"2016","unstructured":"WHO.Global. Manual on surveillance of adverse events following immunization[M]. Switzerland: WHO; 2016. pp. 1\u2013109."},{"issue":"6","key":"22615_CR33","first-page":"609","volume":"27","author":"ZA Chao Ma","year":"2021","unstructured":"Chao Ma ZA, Fujin Wang etc. Giving priority to prevention and serving health, Building the great wall of immunization over the past century - a review of immunization planning work and achievements in the 100 years since the founding of the communist party of China [J]. Chin Vaccine Immun. 2021;27(6):609\u201338.","journal-title":"Chin Vaccine Immun"},{"issue":"1","key":"22615_CR34","doi-asserted-by":"publisher","first-page":"1935170","DOI":"10.1080\/21645515.2021.1935170","volume":"18","author":"M Betancourt-Cravioto","year":"2022","unstructured":"Betancourt-Cravioto M, Cervantes-Powell P, Tapia-Conyer R, Ledlie S, Gandhi-Banga S. Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system. Hum Vaccin Immunother. 2022;18(1):1935170.","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"22615_CR35","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.vaccine.2018.01.018","volume":"36","author":"S Tafuri","year":"2018","unstructured":"Tafuri S, Fortunato F, Gallone MS, Stefanizzi P, Calabrese G, Boccalini S, Martinelli D, Prato R. Systematic causality assessment of adverse events following HPV vaccines: analysis of current data from Apulia region (Italy). Vaccine. 2018;36(8):1072\u20137.","journal-title":"Vaccine"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22615-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22615-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T19:02:47Z","timestamp":1744743767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22615-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22615"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22615-5","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Ethics and Research Committees of Zhejiang CDC (approval number: 2021-002-07, approval date: 2021-11-08). Due to the study\u2019s observational nature and the use of a de-identified dataset, informed consent was waived by the Ethics and Research Committees of Zhejiang CDC. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1410"}}